Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Semyamed AS
AS
Active
Org 924685476
Kavlebruvegen 11, 2312
Ottestad
General medical practice activities
·
NACE 8621
Est. 2020 · 6 years old
1 employees
Monitor
Share
Norway
/
Companies
/
General medical practice activities
/
Semyamed AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
5M
4M
2M
1M
0M
2021: 3M
3M
2021
2022: 3M (0% vs 2021)
3M
0%
2022
2023: 4M (+33% vs 2022)
4M
+33%
2023
2024: 4M (0% vs 2023)
4M
0%
2024
2025: 4M (0% vs 2024)
4M
0%
2025
EBITDA
NOK millions
2M
2M
1M
1M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 2M (+100% vs 2023)
2M
+100%
2024
2025: 2M (0% vs 2024)
2M
0%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
3 724
3 678
3 651
3 290
2 984
Staff expenses
−1 113
−1 133
−1 138
−970
−876
EBITDA
1 538
1 514
1 428
1 212
1 195
Depreciation & amort.
−148
−224
−225
−225
−127
EBIT
1 390
1 290
1 203
987
1 069
Net financials
−8
−20
−32
−20
−3
Profit before tax
1 382
1 270
1 170
967
1 065
Tax
304
280
257
213
234
Net profit
1 078
990
913
754
831
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
2 098
2 130
2 112
1 996
2 656
Equity
31
31
33
30
1 267
Long-term debt
338
439
535
636
1 029
Short-term debt
1 729
1 661
1 543
1 331
360
Total debt
2 068
2 099
2 079
1 966
1 388
Financial ratios
5-year trend
EBITDA margin
41,3 %
This company
15,8 %
Market median
This company
Market median
161% above market
2021
2025
Equity ratio
1,5 %
This company
38,2 %
Market median
This company
Market median
96% below market
2021
2025
Return on equity
>999 %
This company
18,4 %
Market median
This company
Market median
>999% above market
2021
2025
Net profit margin
28,9 %
This company
8,1 %
Market median
This company
Market median
257% above market
2021
2025
Asset turnover
1,77×
This company
1,12×
Market median
This company
Market median
58% above market
2021
2025
Debt / equity
67,36×
This company
0,62×
Market median
This company
Market median
>999% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Semyamed AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
